The orphaned Raven has found a parent. MacroGenics, a Rockville biotech, announced yesterday that it bought cancer drug developer Raven Biotechnologies of South San Francisco, Calif. Until last March, it looked like another biotech firm would be adopting Raven. VaxGen, also of South San Francisco... -
MacroGenics Buys Drug Developer to Bolster Cancer Work
The orphaned Raven has found a parent. MacroGenics, a Rockville biotech, announced yesterday that it bought cancer drug developer Raven Biotechnologies of South San Francisco, Calif. Until last March, it looked like another biotech firm would be adopting Raven. VaxGen, also of South San Francisco...-
By Simone Baribeau